Enfusion (ENFN) Competitors

Enfusion (NYSE:ENFN) and Couchbase (NASDAQ:BASE) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, community ranking, valuation and earnings.

Does the media prefer ENFN or BASE?

In the previous week, Couchbase had 7 more articles in the media than Enfusion. MarketBeat recorded 8 mentions for Couchbase and 1 mentions for Enfusion. Enfusion's average media sentiment score of 0.43 beat Couchbase's score of 0.24 indicating that Enfusion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enfusion	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Couchbase	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals & insiders have more ownership in ENFN or BASE?

49.4% of Enfusion shares are held by institutional investors. Comparatively, 59.2% of Couchbase shares are held by institutional investors. 40.1% of Enfusion shares are held by insiders. Comparatively, 24.6% of Couchbase shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk and volatility, ENFN or BASE?

Enfusion has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Comparatively, Couchbase has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500.

Is ENFN or BASE more profitable?

Enfusion has a net margin of 1.81% compared to Couchbase's net margin of -44.24%. Enfusion's return on equity of 2.81% beat Couchbase's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enfusion	1.81%	2.81%	2.42%
Couchbase	-44.24%	-41.11%	-25.98%

Does the MarketBeat Community believe in ENFN or BASE?

Couchbase received 22 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 39.73% of users gave Couchbase an outperform vote while only 17.50% of users gave Enfusion an outperform vote.

Company	Underperform	Outperform
Enfusion	Outperform Votes 7 17.50%	Underperform Votes 33 82.50%
Couchbase	Outperform Votes 29 39.73%	Underperform Votes 44 60.27%

Do analysts prefer ENFN or BASE?

Enfusion currently has a consensus target price of $11.08, suggesting a potential upside of 37.00%. Couchbase has a consensus target price of $19.40, suggesting a potential downside of 7.75%. Given Enfusion's higher possible upside, research analysts clearly believe Enfusion is more favorable than Couchbase.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enfusion	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Couchbase	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Which has better earnings & valuation, ENFN or BASE?

Enfusion has higher earnings, but lower revenue than Couchbase. Couchbase is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enfusion	$150.35 million	6.26	-$7.65 million	$0.04	202.30
Couchbase	$154.82 million	6.20	-$68.49 million	-$1.53	-13.75

Summary

Enfusion beats Couchbase on 10 of the 18 factors compared between the two stocks.